Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...

Bladder biopsy of normal-looking mucosa, as determined by cystoscopy, might not add clinical value in patients with positive voided-urine cytology after treatment of non-muscle-invasive bladder cancer ...

OSLO, Norway, March 24, 2025 /PRNewswire/ --Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two abstract presentations at the 2025 European Association of Urology congress (EAU) in ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Doctors use a combination of tests, including urinalysis, cystoscopy, urine culture, and bladder wall biopsy to diagnose interstitial cystitis. For males, they may also examine prostate secretions.

Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers. In a study that examined five ...

Host Rick Bangs’s special guest is Yair Lotan, M.D., a Professor of Urology, Chief of Urologic Oncology, at UT Southwestern Medical Center. When do urologists use a cystoscopy and why? What are the ...

Q: Which doctor performs a cystoscopy? A: A urologist performs cystoscopy procedure under local or regional or general anesthesia. Q: How much does a cystoscopic procedure cost? A: Cystoscopy can cost ...

NEW ORLEANS -- Using a tool to classify patients' infection risk and providing education and systems-level changes in the urology department safely reduced prophylactic antibiotic use around ...

If an older patient undergoes general anesthesia, cardiac complications are possible. One urologist forgot that, to his regret. Dr. Y, age 57, is an experienced general urologist who practices at a ...

ORANGEBURG, N.Y., May 13, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the introduction by Stryker Corporation ("Stryker") of the new line of EndoSheath Cystoscopy ...